FMC Corp vs Otis Worldwide Corp — how do they compare? FMC Corp trades at $11.18 (market cap $1.36B), while Otis Worldwide Corp trades at $73.93 (market cap $27.70B). The key difference: Otis Worldwide Corp is far larger — about 20.4× FMC Corp's market cap, and FMC Corp pays the higher dividend (2.95%). Which is the better fit depends on your goals.
| FMC | OTIS | |
|---|---|---|
Market Cap | $1.36B | $27.70B |
Sector | Basic Materials | Industrials |
52-Week High | $43.90 | $101.07 |
52-Week Low | $10.72 | $69.34 |
Enterprise Value | $5.50B | $35.09B |
Dividend Yield | 2.95% | 2.35% |
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.
The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.
Otis Worldwide (OTIS) trades at $72.56, down 1.17% on the day, with technical indicators showing a bearish bias. The company reported mixed recent earnings, beating in Q3 2025 but missing in Q4 2025 and Q1 2026. Revenue growth remains steady, with 2025 revenue of $14.43B and a net income margin of 10.11%. Recent corporate news includes a 5% dividend increase to $0.44 per share and new modernization solution launches in EMEA and Brazil.
The outlook presents a dichotomy: a compelling valuation disconnect versus near-term operational headwinds. The stock trades at a significant discount to the $91.00 analyst consensus target, offering potential upside. However, risks include recent earnings misses, a challenging debt-to-asset ratio of 75.54% (2025), and margin pressure from tariffs and investments, as noted in Q1 2026 results (Zacks, April 22, 2026).
Trailing returns across standard periods
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →